March 28, 2025

FDA Approves Adjuvant Durvalumab/Chemo in Muscle-Invasive Bladder Cancer – CancerNetwork

March 28, 2025

FDA Approves Perioperative Durvalumab Plus Chemo for Muscle-Invasive Bladder Cancer – OncLive

March 22, 2025

Deep learning on T2WI to predict the muscle-invasive bladder cancer: a multi-center clinical study – Nature

March 22, 2025

Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning – Nature

March 14, 2025

Circulating and Urinary Tumor DNA in Bladder Cancer Treatment and Surveillance – Alan Tan – UroToday